CAT# | CPM-1-0674 |
Sequence | FLSPRQPPLL |
Size | 100 test | Storage | 4 ̊C | Epitope Origin | CDK13 FLS | MHC Restriction | HLA-A_02_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0534 | H-2Kb TB10.4 tetramer-IMYNYPAM-APC labeled | Inquiry | ||
CPM-1-0498 | H-2Db HY Uty tetramer-WMHHNMDLI-APC labeled | Inquiry | ||
CPM-1-0608 | HLA-A_02_01 GPC3 tetramer-FVGEFFTDV-APC labeled | Inquiry | ||
CPM-1-0574 | HLA-A_02_01 HCV NS4B 1992-2000 tetramer-VLSDFKTWL-PE labeled | Inquiry | ||
CPM-1-0525 | Mafa-B_104_01 SIV gag NA9 tetramer-NCVGDHQAA-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Dalbavancin, marketed under the brand name of Dalvance, is a new semi-synthetic glycopeptide antibiotic for anti ...
Basic information Desmopressin is a synthetic analogue of the antidiuretic hormone vasopressin used in the treatment of centr ...
10Panx is a panx 1 mimetic inhibitor that easily and reversibly inhibits panx1 currents. In cells that are diffi ...
Today, many attempts have been made to reduce or stop the aging effect on the skin. As the skin ages, wrinkles, lines, brown ...
TC 14012 is a serum-stable derivative of the peptidomimetic T140, which is a cyclic peptide with the structure o ...